Moderna, hoping to prove it's no one-trick COVID pony, posts early peek at mRNA flu shot hopeful AHA, AMA sue Biden admin to challenge surprise billing arbitration process Elizabeth Holmes' defense rests after 7 days of revealing testimony from the ex-Theranos CEO Lawmakers blast pharma for 'outrageous' prices and 'anticompetitive conduct' in culmination of 3-year probe Medtronic’s Covidien faces another Class I recall of beleaguered Puritan Bennett ventilators Roche posts 'impressive' TIGIT combo lung cancer data, but trial deaths weigh down shares J&J celebrates nurses with a new campaign in wake of burnout plaguing the profession Novartis CEO Narashimhan confirms interest in purchase of generics unit Sandoz: report Senate passes bill to delay nearly 10% in Medicare cuts expected to start in January Klick Health spreads good cheer, and $100 bills, in annual holiday video highlighting the joy of giving Moderna taps Carnegie Mellon for in-house AI training academy Super-fit mice reveal anti-inflammatory protein that could boost search for Alzheimer's drugs AHA, Johns Hopkins, Athenahealth, others launch campaign to make telehealth permanent Featured Story | By Ben Adams Moderna is set to make tens of billions of dollars this year and next from its mRNA COVID vaccine and booster, but the market won’t let the Big Biotech rest on its laurels and wants broader applicability from its programs. read more |
| |
|---|
|
| | The PerkinElmer Biotech Bundle is deployed via Amazon CloudFormation and provides the most advanced analytical package for drug discovery available today. Affordable and easy to get started. Learn more. |
Top Stories By Paige Minemyer Rules finalized under the act have drawn significant ire from providers. They outline an arbitration model to resolve surprise billing disputes, which providers say favors health insurers in the negotiations. read more By Andrea Park The disgraced Theranos founder's legal team wrapped up the proceedings following Holmes’ more than 25 hours of questioning. read more By Fraiser Kansteiner The House Oversight Committee's findings mark the culmination of an almost three-year probe into the industry's pricing strategies, launched by the late Rep. Elijah Cummings in 2019. The report cites more than 1.5 million pages of internal company documents that shed light on "the decision-making of many of the world's most profitable drug companies," the committee said. read more By Andrea Park When it put down a casual $43 billion to merge with Covidien in 2015, Medtronic inherited its Irish partner’s Dublin headquarters and wide range of medical devices—and, consequently, any and all of their accompanying safety issues. read more By Ben Adams New follow-up data for Roche’s Tecentriq-tiragolumab combination therapy in certain lung cancer patients have analysts sighing in relief that the anti-TIGIT element appears to be pulling its weight. read more By Sharon Klahr Coey Nurses deserve more than just a “thank you” for all they contribute, but Johnson & Johnson knows that appreciation is a good place to start. Continuing the company’s 120 year commitment to the nursing profession, J&J launched a new digital and print campaign to celebrate nurses and the work they’ve done during the pandemic and beyond. read more By Kevin Dunleavy Novartis CEO Vas Narashimhan confirmed buyer interest in a purchase of the company's generics unit Sandoz. Last month Swedish investment group EQT and the billionaire Struengmann brothers of Germany were said to be considering a purchase for $21.6 billion. read more By Robert King The Senate passed a bill late Thursday that delays nearly 10% in cuts to Medicare set to start in January, as provider groups hope lawmakers now work on a more permanent fix. read more By Natalie Missakian Klick Health's annual holiday video started as a thank-you to clients but grew into a beloved tradition—and unwitting recruiting tool. This year, it mailed employees each a $100 bill and asked them to use it however they wished to spread joy. read more By Conor Hale As it looks to one day move beyond COVID-19 vaccines and take its mRNA tech to other diseases, Moderna has established a new artificial intelligence training program for its employees in partnership with Carnegie Mellon University. The company’s AI Academy represents a “broader investment in a digital-first culture,” with curriculums designed for working professionals. read more By Arlene Weintraub A Stanford team discovered that a protein called clusterin is prevalent in exercising mice and prompts anti-inflammatory, brain-boosting effects. They concluded that a drug that reduces inflammation in the brain by mimicking the binding of clusterin to endothelial cells could prove effective in Alzheimer’s and other diseases. read more By Anastassia Gliadkovskaya Telehealth access is under threat as the temporary lift on the usual restrictions is set to end in January, several organizations say. The public health emergency order that allows for the exemption was already renewed six times by the Department of Health and Human Services. read more |
